Helix Therapeutics developed DNA-based therapeutics for the treatment of HIV/AIDS and common genetic diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: New Haven
State: Connecticut
Zip:
Country: United States
Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2010 | Seed Round | 1 | $600k |
LaunchCapital LaunchCapital |
11/2010 | Series A | 2 | $2.5M |
Canaan Partners Connecticut Innovations Canaan Partners Connecticut Innovations |
3/2009 | Debt Financing | $262.5k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|